temazepam Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
diazepam derivatives 2585 846-50-4

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • temazepam
  • (RS)-Temazepam
  • levanxene
  • levanxol
A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.
  • Molecular weight: 300.74
  • Formula: C16H13ClN2O2
  • CLOGP: 2.34
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 1
  • TPSA: 52.90
  • ALOGS: -3.75
  • ROTB: 1

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
20 mg O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 1 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 0.60 mg/mL Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 0.50 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 0.83 ┬ÁM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability) 91 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H

Approvals:

DateAgencyCompanyOrphan
Feb. 27, 1981 FDA MALLINCKRODT INC

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Completed suicide 397.09 10.47 546 46446 137655 53164419
Toxicity to various agents 369.58 10.47 679 46313 218919 53083155
Temperature regulation disorder 213.73 10.47 94 46898 4113 53297961
Coeliac disease 172.00 10.47 103 46889 8632 53293442
Overdose 165.63 10.47 321 46671 107415 53194659
Food allergy 156.89 10.47 95 46897 8123 53293951
Immunodeficiency 111.85 10.47 98 46894 14869 53287205
Respiratory arrest 96.76 10.47 133 46859 33407 53268667
Bursitis 95.05 10.47 108 46884 22384 53279690
Maternal exposure during pregnancy 86.88 10.47 16 46976 155623 53146451
Hyperhidrosis 84.73 10.47 231 46761 96562 53205512
Drug ineffective 81.83 10.47 407 46585 816838 52485236
Myocardial depression 81.47 10.47 26 46966 455 53301619
Synovitis 75.40 10.47 5 46987 107888 53194186
Drug intolerance 70.82 10.47 47 46945 205446 53096628
Off label use 69.26 10.47 201 46791 472011 52830063
Rash erythematous 68.92 10.47 121 46871 37502 53264572
Decorticate posture 67.38 10.47 21 46971 339 53301735
Fluid retention 65.80 10.47 147 46845 54254 53247820
Hand deformity 62.15 10.47 3 46989 84846 53217228
Poisoning 61.06 10.47 68 46924 13782 53288292
Accidental overdose 57.22 10.47 82 46910 21397 53280677
Cardiac arrest 57.10 10.47 197 46795 93470 53208604
Drug abuse 53.00 10.47 152 46840 65374 53236700
Constipation 51.63 10.47 325 46667 198087 53103987
Arthropathy 49.19 10.47 32 46960 141421 53160653
Insomnia 48.40 10.47 306 46686 186766 53115308
Infusion related reaction 46.90 10.47 41 46951 155916 53146158
Substance abuse 45.25 10.47 35 46957 4459 53297615
Exposure during pregnancy 43.75 10.47 28 46964 124832 53177242
Glossodynia 43.38 10.47 17 46975 100274 53201800
Systemic lupus erythematosus 42.76 10.47 29 46963 125385 53176689
Wound 42.18 10.47 14 46978 91543 53210531
Abdominal discomfort 41.08 10.47 83 46909 220979 53081095
Victim of sexual abuse 40.70 10.47 16 46976 525 53301549
Cardio-respiratory arrest 40.63 10.47 129 46863 58629 53243445
Rash 40.08 10.47 230 46762 445961 52856113
Swelling 39.72 10.47 67 46925 191038 53111036
Back pain 39.41 10.47 346 46646 233901 53068173
Respiratory depression 38.77 10.47 52 46940 12754 53289320
Libido increased 38.18 10.47 19 46973 1102 53300972
Hostility 36.70 10.47 21 46971 1616 53300458
Treatment failure 35.95 10.47 36 46956 128367 53173707
Upper respiratory tract infection 35.90 10.47 138 46854 68959 53233115
Impaired reasoning 35.54 10.47 9 46983 64 53302010
Pericarditis 35.11 10.47 7 46985 64399 53237675
Coma scale abnormal 34.91 10.47 32 46960 5146 53296928
Venous pressure jugular increased 34.78 10.47 15 46977 625 53301449
Discomfort 34.00 10.47 21 46971 95451 53206623
Arthralgia 33.68 10.47 238 46754 439545 52862529
Hypothermia 33.54 10.47 49 46943 13007 53289067
Asthma 33.12 10.47 186 46806 108786 53193288
Infected dermal cyst 32.31 10.47 13 46979 454 53301620
Amblyopia 31.34 10.47 11 46981 261 53301813
Anxiety 30.74 10.47 286 46706 196418 53105656
Transplant dysfunction 30.38 10.47 29 46963 4909 53297165
Peripheral swelling 29.91 10.47 88 46904 206020 53096054
Sternal fracture 29.03 10.47 19 46973 1860 53300214
Judgement impaired 28.25 10.47 13 46979 633 53301441
Post-traumatic neck syndrome 28.04 10.47 18 46974 1705 53300369
Intentional overdose 26.93 10.47 124 46868 67081 53234993
Soft tissue injury 26.90 10.47 16 46976 1323 53300751
Joint swelling 26.78 10.47 111 46881 234527 53067547
Suicidal ideation 26.77 10.47 115 46877 60396 53241678
Thiopurine methyltransferase decreased 25.79 10.47 10 46982 316 53301758
Drug withdrawal syndrome 25.61 10.47 68 46924 27954 53274120
Band neutrophil percentage increased 25.50 10.47 9 46983 217 53301857
Apnoea 25.49 10.47 33 46959 7820 53294254
Therapeutic product effect incomplete 25.38 10.47 26 46966 91758 53210316
Toxicologic test abnormal 24.81 10.47 12 46980 654 53301420
Somnambulism 24.63 10.47 27 46965 5375 53296699
Rectal prolapse 24.32 10.47 17 46975 1854 53300220
Myelocyte percentage increased 23.84 10.47 8 46984 165 53301909
Kyphosis 23.73 10.47 19 46973 2545 53299529
Miosis 22.07 10.47 29 46963 6973 53295101
Urine oxalate increased 21.92 10.47 8 46984 213 53301861
Ventricular hypokinesia 21.79 10.47 23 46969 4389 53297685
Band neutrophil count increased 21.29 10.47 9 46983 357 53301717
Personality disorder 21.23 10.47 22 46970 4109 53297965
Mental disorder 21.12 10.47 58 46934 24318 53277756
Neutropenia 20.95 10.47 71 46921 159114 53142960
Oesophagitis ulcerative 20.92 10.47 10 46982 531 53301543
Homicide 20.80 10.47 9 46983 378 53301696
Panic attack 20.62 10.47 53 46939 21365 53280709
Depression 20.53 10.47 249 46743 182803 53119271
Tremor 20.22 10.47 184 46808 125552 53176522
Retinal depigmentation 19.97 10.47 8 46984 276 53301798
Alopecia 19.90 10.47 123 46869 234460 53067614
Withdrawal syndrome 19.88 10.47 49 46943 19252 53282822
Rheumatoid arthritis 19.53 10.47 180 46812 314351 52987723
Analgesic drug level above therapeutic 19.49 10.47 7 46985 178 53301896
Therapeutic product effect decreased 19.44 10.47 52 46940 125603 53176471
Interstitial lung disease 19.38 10.47 14 46978 58608 53243466
Suspected product quality issue 19.23 10.47 7 46985 185 53301889
Somnolence 18.73 10.47 228 46764 167506 53134568
Poisoning deliberate 18.58 10.47 30 46962 8683 53293391
Unresponsive to stimuli 18.38 10.47 68 46924 33358 53268716
Accidental death 18.33 10.47 14 46978 1750 53300324
Folliculitis 18.24 10.47 3 46989 31706 53270368
Rectal polyp 17.88 10.47 11 46981 967 53301107
Bundle branch block left 17.55 10.47 26 46966 6987 53295087
Contraindicated product administered 17.50 10.47 61 46931 135568 53166506
Atrioventricular block first degree 17.48 10.47 25 46967 6510 53295564
Myelocyte count increased 17.47 10.47 8 46984 385 53301689
Nasopharyngitis 17.27 10.47 99 46893 192196 53109878
Nightmare 17.17 10.47 44 46948 17707 53284367
Dystrophic calcification 16.95 10.47 6 46986 146 53301928
Depressed mood 16.93 10.47 71 46921 36893 53265181
Hepatocellular injury 16.89 10.47 3 46989 29983 53272091
Poor quality sleep 16.82 10.47 43 46949 17280 53284794
Pulmonary congestion 16.62 10.47 41 46951 16115 53285959
Infection 16.37 10.47 87 46905 172118 53129956
Abnormal behaviour 16.02 10.47 49 46943 21817 53280257
Ovarian cyst 15.98 10.47 39 46953 15230 53286844
Hypovolaemia 15.95 10.47 31 46961 10371 53291703
Duodenal ulcer 15.89 10.47 26 46966 7610 53294464
Homicidal ideation 15.85 10.47 13 46979 1801 53300273
Abortion spontaneous 15.59 10.47 11 46981 46624 53255450
Suspected counterfeit product 15.36 10.47 7 46985 333 53301741
Upper respiratory tract congestion 15.35 10.47 13 46979 1882 53300192
Arteriosclerosis coronary artery 15.23 10.47 27 46965 8427 53293647
Injection site erythema 15.20 10.47 28 46964 77221 53224853
Duodenal ulcer perforation 15.15 10.47 6 46986 35177 53266897
Dehydration 15.10 10.47 220 46772 168190 53133884
Gastrointestinal disorder 14.88 10.47 36 46956 89968 53212106
Postmortem blood drug level increased 14.76 10.47 8 46984 554 53301520
Sensitisation 14.70 10.47 11 46981 1334 53300740
Urticaria 14.44 10.47 66 46926 135819 53166255
Monocyte percentage increased 14.42 10.47 10 46982 1077 53300997
Suicide attempt 14.30 10.47 94 46898 58074 53244000
Bruxism 14.23 10.47 16 46976 3275 53298799
Calculus urethral 14.22 10.47 3 46989 8 53302066
Psoriatic arthropathy 14.07 10.47 13 46979 48177 53253897
Transplant rejection 14.07 10.47 29 46963 10122 53291952
Mass 13.94 10.47 33 46959 12636 53289438
Specific gravity urine decreased 13.93 10.47 8 46984 620 53301454
C-reactive protein increased 13.90 10.47 24 46968 67862 53234212
Premature delivery 13.89 10.47 3 46989 26101 53275973
Akathisia 13.71 10.47 26 46966 8545 53293529
Febrile neutropenia 13.67 10.47 47 46945 104889 53197185
Musculoskeletal stiffness 13.66 10.47 59 46933 123309 53178765
Intentional product use issue 13.63 10.47 27 46965 72467 53229607
Mood swings 13.58 10.47 40 46952 17446 53284628
Amnesia 13.55 10.47 77 46915 45211 53256863
Cardiac failure congestive 13.54 10.47 133 46859 92624 53209450
Cardioactive drug level above therapeutic 13.24 10.47 5 46987 147 53301927
Bacterial test 13.10 10.47 10 46982 1249 53300825
Respiratory alkalosis 13.08 10.47 14 46978 2714 53299360
Loss of consciousness 13.07 10.47 156 46836 114056 53188018
General physical health deterioration 13.00 10.47 76 46916 146866 53155208
Arteriosclerosis 12.98 10.47 28 46964 10083 53291991
Muscle injury 12.94 10.47 5 46987 29761 53272313
Stomatitis 12.76 10.47 44 46948 98114 53203960
Peptic ulcer perforation 12.72 10.47 5 46987 164 53301910
Blister 12.63 10.47 32 46960 78721 53223353
Hyperthermia 12.49 10.47 25 46967 8544 53293530
Leukopenia 12.45 10.47 29 46963 73434 53228640
Clonus 12.34 10.47 17 46975 4274 53297800
Road traffic accident 12.34 10.47 50 46942 25581 53276493
Microscopic polyangiitis 12.33 10.47 5 46987 178 53301896
Dilatation atrial 12.13 10.47 12 46980 2122 53299952
Stress 12.12 10.47 89 46903 56995 53245079
Memory impairment 12.11 10.47 121 46871 84636 53217438
Drug reaction with eosinophilia and systemic symptoms 11.97 10.47 7 46985 32793 53269281
Foetal exposure during pregnancy 11.86 10.47 8 46984 34707 53267367
Septic shock 11.85 10.47 23 46969 62206 53239868
Rib fracture 11.78 10.47 42 46950 20236 53281838
Thrombocytopenia 11.62 10.47 73 46919 138654 53163420
Irritability 11.58 10.47 56 46936 30897 53271177
Change of bowel habit 11.25 10.47 11 46981 1917 53300157
Post-traumatic pain 11.24 10.47 6 46986 403 53301671
Acquired immunodeficiency syndrome 11.05 10.47 4 46988 104 53301970
Vitamin B1 deficiency 10.91 10.47 5 46987 241 53301833
Subendocardial ischaemia 10.87 10.47 4 46988 109 53301965
Middle insomnia 10.83 10.47 27 46965 10681 53291393
Acute kidney injury 10.78 10.47 158 46834 253710 53048364
Cholestasis 10.65 10.47 6 46986 28689 53273385
Ill-defined disorder 10.57 10.47 17 46975 49427 53252647

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Toxicity to various agents 596.42 11.37 745 27067 177296 32308418
Completed suicide 345.55 11.37 410 27402 92107 32393607
Drug abuse 173.30 11.37 273 27539 79970 32405744
Aggression 97.62 11.37 143 27669 39246 32446468
Dysarthria 96.34 11.37 130 27682 33071 32452643
Overdose 82.48 11.37 210 27602 86867 32398847
Substance abuse 74.47 11.37 56 27756 7051 32478663
Logorrhoea 71.18 11.37 37 27775 2425 32483289
Off label use 66.17 11.37 100 27712 306220 32179494
Intrusive thoughts 63.73 11.37 18 27794 209 32485505
Poisoning 54.45 11.37 57 27755 11101 32474613
Dystonic tremor 51.63 11.37 15 27797 194 32485520
Drug dependence 50.70 11.37 80 27732 23404 32462310
Accidental overdose 50.49 11.37 72 27740 19267 32466447
Bradyphrenia 47.44 11.37 36 27776 4593 32481121
Suicidal ideation 47.09 11.37 102 27710 37981 32447733
Abnormal behaviour 42.43 11.37 79 27733 26387 32459327
Insomnia 42.31 11.37 184 27628 100164 32385550
Homicidal ideation 41.89 11.37 27 27785 2653 32483061
Psychotic disorder 41.09 11.37 72 27740 22948 32462766
Bradykinesia 41.01 11.37 32 27780 4254 32481460
Suicide attempt 40.14 11.37 96 27716 38148 32447566
Sedation 37.11 11.37 61 27751 18465 32467249
Coordination abnormal 36.77 11.37 39 27773 7709 32478005
Restlessness 35.87 11.37 71 27741 24810 32460904
Tachyphrenia 34.31 11.37 18 27794 1202 32484512
Injury 33.92 11.37 65 27747 22180 32463534
Anxiety 33.79 11.37 167 27645 95838 32389876
Depressed level of consciousness 29.21 11.37 89 27723 40758 32444956
Pulmonary congestion 28.55 11.37 45 27767 13146 32472568
Psychotic behaviour 27.92 11.37 13 27799 670 32485044
Anger 26.31 11.37 41 27771 11863 32473851
Drug withdrawal syndrome 25.93 11.37 55 27757 20176 32465538
Crystalluria 25.19 11.37 11 27801 487 32485227
Behaviour disorder 24.22 11.37 22 27790 3602 32482112
Accidental poisoning 23.82 11.37 11 27801 556 32485158
Febrile neutropenia 22.96 11.37 42 27770 119524 32366190
Mesothelioma 22.85 11.37 10 27802 445 32485269
Hallucination, auditory 21.98 11.37 35 27777 10315 32475399
Congestive hepatopathy 21.92 11.37 16 27796 1924 32483790
Drug abuser 21.54 11.37 22 27790 4162 32481552
Interstitial lung disease 20.98 11.37 15 27797 64986 32420728
Homicide 20.86 11.37 12 27800 961 32484753
Restless legs syndrome 20.80 11.37 29 27783 7595 32478119
Irritability 20.79 11.37 57 27755 24597 32461117
Miosis 20.67 11.37 31 27781 8673 32477041
Respiratory depression 20.62 11.37 39 27773 13172 32472542
Emotional disorder 20.03 11.37 24 27788 5417 32480297
General physical health deterioration 19.97 11.37 43 27769 115216 32370498
Drug level below therapeutic 19.70 11.37 21 27791 4174 32481540
Drug interaction 19.56 11.37 278 27534 217907 32267807
Paranoia 19.55 11.37 34 27778 10765 32474949
Mood swings 19.28 11.37 29 27783 8136 32477578
Drug ineffective 19.17 11.37 223 27589 383254 32102460
Mental disorder 19.16 11.37 40 27772 14508 32471206
Osmolar gap abnormal 19.05 11.37 5 27807 43 32485671
Somnambulism 18.49 11.37 18 27794 3214 32482500
Cardiac asthma 18.14 11.37 7 27805 225 32485489
Personality change 18.11 11.37 22 27790 5037 32480677
Patient uncooperative 17.79 11.37 8 27804 380 32485334
Drug screen positive 17.78 11.37 20 27792 4221 32481493
Depersonalisation/derealisation disorder 17.32 11.37 9 27803 589 32485125
Depression 17.30 11.37 142 27670 96918 32388796
Conduction disorder 17.21 11.37 14 27798 1976 32483738
Emotional distress 17.17 11.37 41 27771 16265 32469449
Agitation 16.97 11.37 95 27717 57141 32428573
Sexually transmitted disease 16.64 11.37 4 27808 23 32485691
Blood disorder 16.39 11.37 17 27795 3273 32482441
Hepatic function abnormal 16.32 11.37 9 27803 44831 32440883
Lethargy 16.14 11.37 74 27738 41154 32444560
Accidental death 16.11 11.37 14 27798 2163 32483551
Somnolence 15.96 11.37 147 27665 103650 32382064
Contraindication to medical treatment 15.84 11.37 8 27804 493 32485221
Nonalcoholic fatty liver disease 15.58 11.37 7 27805 332 32485382
Treatment failure 15.55 11.37 7 27805 39156 32446558
Memory impairment 15.36 11.37 72 27740 40407 32445307
Nervousness 14.93 11.37 33 27779 12446 32473268
Thinking abnormal 14.73 11.37 21 27791 5614 32480100
Victim of crime 14.64 11.37 7 27805 383 32485331
Vestibular disorder 14.61 11.37 10 27802 1086 32484628
Renal impairment 14.56 11.37 36 27776 91936 32393778
Gait disturbance 14.52 11.37 118 27694 80290 32405424
Unresponsive to stimuli 14.29 11.37 54 27758 27555 32458159
Poisoning deliberate 14.15 11.37 22 27790 6353 32479361
Tangentiality 14.07 11.37 5 27807 127 32485587
Foetal exposure during pregnancy 14.03 11.37 9 27803 41292 32444422
Needle fatigue 13.96 11.37 7 27805 425 32485289
Product use in unapproved indication 13.91 11.37 34 27778 87170 32398544
Cerebral arteriovenous malformation haemorrhagic 13.89 11.37 4 27808 50 32485664
Sexually inappropriate behaviour 13.49 11.37 7 27805 457 32485257
Breast cancer male 13.27 11.37 6 27806 289 32485425
Exposure via ingestion 13.25 11.37 13 27799 2344 32483370
Physical disability 13.14 11.37 10 27802 1281 32484433
Confusional state 13.06 11.37 183 27629 142932 32342782
Pyrexia 13.05 11.37 194 27618 319774 32165940
Alcohol poisoning 12.92 11.37 15 27797 3274 32482440
Cardiomegaly 12.86 11.37 35 27777 15036 32470678
Gait spastic 12.75 11.37 7 27805 512 32485202
Dysprosody 12.37 11.37 3 27809 18 32485696
Obsessive-compulsive disorder 12.33 11.37 18 27794 4916 32480798
Acute kidney injury 11.93 11.37 178 27634 293290 32192424
Borderline personality disorder 11.82 11.37 6 27806 374 32485340
Coma scale abnormal 11.74 11.37 15 27797 3612 32482102
Relapsing-remitting multiple sclerosis 11.57 11.37 7 27805 615 32485099
Fear 11.42 11.37 28 27784 11291 32474423
Neck injury 11.38 11.37 9 27803 1219 32484495
Urticaria 11.38 11.37 21 27791 59593 32426121

Pharmacologic Action:

SourceCodeDescription
ATC N05CD07 NERVOUS SYSTEM
PSYCHOLEPTICS
HYPNOTICS AND SEDATIVES
Benzodiazepine derivatives
FDA CS M0002356 Benzodiazepines
MeSH PA D014151 Anti-Anxiety Agents
MeSH PA D002491 Central Nervous System Agents
MeSH PA D002492 Central Nervous System Depressants
MeSH PA D018682 GABA Agents
MeSH PA D018757 GABA Modulators
MeSH PA D006993 Hypnotics and Sedatives
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D011619 Psychotropic Drugs
MeSH PA D014149 Tranquilizing Agents
FDA EPC N0000175694 Benzodiazepine

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Insomnia indication 193462001
Suicidal thoughts contraindication 6471006
Alcohol intoxication contraindication 25702006
Depressive disorder contraindication 35489007
Substance abuse contraindication 66214007
Sleep apnea contraindication 73430006 DOID:0050847
Kidney disease contraindication 90708001 DOID:557
Hypoalbuminemia contraindication 119247004
Disease of liver contraindication 235856003 DOID:409
Sleep automatism contraindication 247962006
Pregnancy, function contraindication 289908002
Severe chronic obstructive pulmonary disease contraindication 313299006
Memory impairment contraindication 386807006
Chronic lung disease contraindication 413839001

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.07 acidic
pKa2 1.46 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
GABA-A receptor alpha-1/beta-2/gamma-2 Ion channel POSITIVE ALLOSTERIC MODULATOR WOMBAT-PK CHEMBL
Nuclear receptor subfamily 1 group I member 3 Nuclear hormone receptor WOMBAT-PK

External reference:

IDSource
4017894 VUID
N0000146246 NUI
D00370 KEGG_DRUG
4017894 VANDF
C0039468 UMLSCUI
CHEBI:9435 CHEBI
CHEMBL967 ChEMBL_ID
DB00231 DRUGBANK_ID
D013693 MESH_DESCRIPTOR_UI
5391 PUBCHEM_CID
7300 IUPHAR_LIGAND_ID
2753 INN_ID
CHB1QD2QSS UNII
10355 RXNORM
2322 MMSL
5544 MMSL
d00384 MMSL
001450 NDDF
387300007 SNOMEDCT_US
54705000 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 0228-2076 CAPSULE 15 mg ORAL ANDA 19 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 0228-2077 CAPSULE 30 mg ORAL ANDA 19 sections
RESTORIL HUMAN PRESCRIPTION DRUG LABEL 1 0406-9914 CAPSULE 22.50 mg ORAL NDA 26 sections
RESTORIL HUMAN PRESCRIPTION DRUG LABEL 1 0406-9915 CAPSULE 7.50 mg ORAL NDA 26 sections
RESTORIL HUMAN PRESCRIPTION DRUG LABEL 1 0406-9916 CAPSULE 15 mg ORAL NDA 26 sections
RESTORIL HUMAN PRESCRIPTION DRUG LABEL 1 0406-9917 CAPSULE 30 mg ORAL NDA 26 sections
TEMAZEPAM HUMAN PRESCRIPTION DRUG LABEL 1 0406-9959 CAPSULE 22.50 mg ORAL NDA 26 sections
TEMAZEPAM HUMAN PRESCRIPTION DRUG LABEL 1 0406-9960 CAPSULE 7.50 mg ORAL NDA 26 sections
TEMAZEPAM HUMAN PRESCRIPTION DRUG LABEL 1 0406-9961 CAPSULE 15 mg ORAL NDA 26 sections
TEMAZEPAM HUMAN PRESCRIPTION DRUG LABEL 1 0406-9962 CAPSULE 30 mg ORAL NDA 26 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 0615-7808 CAPSULE 15 mg ORAL ANDA 27 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 0615-7809 CAPSULE 30 mg ORAL ANDA 27 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 0904-6436 CAPSULE 7.50 mg ORAL ANDA 24 sections
TEMAZEPAM HUMAN PRESCRIPTION DRUG LABEL 1 16590-214 CAPSULE 15 mg ORAL ANDA 14 sections
temazepam Human Prescription Drug Label 1 17856-0148 CAPSULE 15 mg ORAL ANDA 23 sections
temazepam HUMAN PRESCRIPTION DRUG LABEL 1 21695-282 CAPSULE 15 mg ORAL ANDA 24 sections
temazepam HUMAN PRESCRIPTION DRUG LABEL 1 21695-283 CAPSULE 30 mg ORAL ANDA 24 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 33261-101 CAPSULE 15 mg ORAL ANDA 23 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 33261-102 CAPSULE 30 mg ORAL ANDA 23 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 33358-332 CAPSULE 15 mg ORAL ANDA 18 sections
temazepam HUMAN PRESCRIPTION DRUG LABEL 1 35356-663 CAPSULE 30 mg ORAL ANDA 23 sections
temazepam HUMAN PRESCRIPTION DRUG LABEL 1 35356-664 CAPSULE 15 mg ORAL ANDA 23 sections
temazepam HUMAN PRESCRIPTION DRUG LABEL 1 35356-821 CAPSULE 22.50 mg ORAL ANDA 23 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 40032-120 CAPSULE 7.50 mg ORAL ANDA 17 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 40032-121 CAPSULE 15 mg ORAL ANDA 17 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 40032-122 CAPSULE 22.50 mg ORAL ANDA 17 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 40032-123 CAPSULE 30 mg ORAL ANDA 17 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 42291-797 CAPSULE 7.50 mg ORAL ANDA 26 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 42549-561 CAPSULE 30 mg ORAL ANDA 21 sections
Temazepam HUMAN PRESCRIPTION DRUG LABEL 1 42549-651 CAPSULE 15 mg ORAL ANDA 21 sections